Phase 1 Recruiting
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer Sponsored by Volastra Therapeutics, Inc.
About this study This is a first-in-human phase I/II study to examine the safety, tolerability and preliminary efficacy of VLS-1488 in subjects with advanced cancers.
Enrolling at this location M.D. Anderson Cancer Center
Houston, Texas
I'm interested This study also enrolls at 13 other locations. See all .
Study details Conditions
Advanced Solid Tumor High Grade Serous Adenocarcinoma of Ovary Squamous Non-small-cell Lung Cancer Triple Negative Breast Cancer Head and Neck Squamous Cell Carcinoma Ovarian Carcinosarcoma Uterine Carcinosarcoma Uterine Serous Carcinoma Endometrium Cancer Chromosomal Instability
Gender
All genders welcome
Healthy volunteers
Not accepted
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov .
Clinably Connecting patients with clinical research opportunities near them.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you meet the criteria to participate. Results are based on the information you provide and are intended to help you start a conversation with the research team.
© 2026 Clinably. Trial data sourced from ClinicalTrials.gov.